BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 20470050)

  • 1. Risk of sequelae after Chlamydia trachomatis genital infection in women.
    Haggerty CL; Gottlieb SL; Taylor BD; Low N; Xu F; Ness RB
    J Infect Dis; 2010 Jun; 201 Suppl 2():S134-55. PubMed ID: 20470050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute pelvic inflammatory disease.
    Eschenbach DA
    Urol Clin North Am; 1984 Feb; 11(1):65-81. PubMed ID: 6369707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know?
    Gottlieb SL; Berman SM; Low N
    J Infect Dis; 2010 Jun; 201 Suppl 2():S156-67. PubMed ID: 20470051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlamydia trachomatis: impact on human reproduction.
    Paavonen J; Eggert-Kruse W
    Hum Reprod Update; 1999; 5(5):433-47. PubMed ID: 10582782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute pelvic inflammatory disease.
    Freij BJ
    Semin Adolesc Med; 1986 Jun; 2(2):143-53. PubMed ID: 3602634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme immunoassay in the diagnosis of Chlamydia trachomatis infections in diverse patient groups.
    Bakir TM; Hossain A; De-Silva S; Siddiqui A; Sengupta BS; el-Sheikh MM; Bakir AF
    J Hyg Epidemiol Microbiol Immunol; 1989; 33(2):189-97. PubMed ID: 2671155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the number of genital chlamydial infections in the United States.
    Judson FN
    J Reprod Med; 1985 Mar; 30(3 Suppl):269-72. PubMed ID: 4020783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies.
    Geisler WM
    J Infect Dis; 2010 Jun; 201 Suppl 2():S104-13. PubMed ID: 20470048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening.
    Land JA; Van Bergen JE; Morré SA; Postma MJ
    Hum Reprod Update; 2010; 16(2):189-204. PubMed ID: 19828674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Productivity losses attributable to untreated chlamydial infection and associated pelvic inflammatory disease in reproductive-aged women.
    Blandford JM; Gift TL
    Sex Transm Dis; 2006 Oct; 33(10 Suppl):S117-21. PubMed ID: 17003678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses.
    van Valkengoed IG; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ
    Int J Epidemiol; 2004 Apr; 33(2):416-25. PubMed ID: 15082651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the laboratory in a Chlamydia control programme in a developing country.
    Peeling RW; Oyelese AO; Brunham RC; Achola JO; Ronald AR
    East Afr Med J; 1992 Sep; 69(9):508-14. PubMed ID: 1286634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of pelvic inflammatory disease in untreated women infected with Chlamydia trachomatis: a structured review.
    Risser WL; Risser JM
    Int J STD AIDS; 2007 Nov; 18(11):727-31. PubMed ID: 18005504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing infective sequelae of abortion.
    Penney GC
    Hum Reprod; 1997 Nov; 12(11 Suppl):107-12. PubMed ID: 9433966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Douching, pelvic inflammatory disease, and incident gonococcal and chlamydial genital infection in a cohort of high-risk women.
    Ness RB; Hillier SL; Kip KE; Richter HE; Soper DE; Stamm CA; McGregor JA; Bass DC; Rice P; Sweet RL
    Am J Epidemiol; 2005 Jan; 161(2):186-95. PubMed ID: 15632269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chlamydia trachomatis infection in women and the use of oral contraceptives].
    van Voorst Vader PC; Lier JG; Posma AL; Schröder FP; Schirm J; Kauer FM
    Ned Tijdschr Geneeskd; 1991 Feb; 135(8):323-7. PubMed ID: 2008220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic inflammatory disease.
    Brabin L
    Afr Health; 1993 Mar; 15(3):15-7. PubMed ID: 12344839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlamydia trachomatis in pelvic inflammatory disease.
    Shrikhande SN; Joshi SG; Zodpey SP; Saoji AM
    Indian J Pathol Microbiol; 1995 Apr; 38(2):181-4. PubMed ID: 8919106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydial infection in a population of Ethiopian women attending obstetric, gynaecological and mother and child health clinics.
    Duncan ME; Jamil Y; Tibaux G; Pelzer A; Mehari L; Darougar S
    Cent Afr J Med; 1996 Jan; 42(1):1-14. PubMed ID: 8868379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic inflammatory disease (PID) from Chlamydia trachomatis versus PID from Neisseria gonorrhea: from clinical suspicion to therapy.
    De Seta F; Banco R; Turrisi A; Airoud M; De Leo R; Stabile G; Ceccarello M; Restaino S; De Santo D
    G Ital Dermatol Venereol; 2012 Oct; 147(5):423-30. PubMed ID: 23007248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.